Sort
48,018 grants matching “immunotherapy”
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer
$665,352Natalie Vokes · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Tissue ProcessingSequencing Core
$665,306Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care
$665,218Nancy L Keating · Harvard Medical School · R01 · FY2024 · CA
Lab Research Training in Pediatric Oncology-Hematology
$665,090Alan D Friedman · Johns Hopkins University · T32 · FY2024 · CA
A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-601) Administered to Patients with Relapsed Non-Hodgkin Lymphoma
$665,000Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-601) Administered to Patients with Relapsed Non-Hodgkin Lymphoma
$665,000Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2025 · CA
Developing a novel combination immunotherapy for triple-negative breast cancer
$664,874Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2023 · CA
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$664,854Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · DE
Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE
$664,838Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy
$664,834Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · NS
Elucidating the role of transcriptomics in driving ethnicity and ancestry-related disparities in colorectal cancer
$664,795Jane C. Figueiredo · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy
$664,782Yang Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
$664,636Fei Chen · Broad Institute, Inc. · R01 · FY2024 · CA
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations
$664,591Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · HG
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations
$664,591Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · HG
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations
$664,591Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · HG
A universal intranasal nanoengineered therapy against airborne RNA viruses
$664,392Vinay Subhash Mahajan · Brigham And Women'S Hospital · R01 · FY2025 · EB
A universal intranasal nanoengineered therapy against airborne RNA viruses
$664,392Vinay Subhash Mahajan · Brigham And Women'S Hospital · R01 · FY2024 · EB
Biological and social determinants of psychosocial sequelae in advanced head and neck cancer survivors receiving immunotherapy
$664,304Canhua Xiao · Emory University · R01 · FY2024 · CA
A digital intervention to improve skin self-examination among melanoma survivors
$664,230Sharon L Manne · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
$664,088Yvonne L Kapila · University Of California Los Angeles · R01 · FY2022 · CA
BAFF-R CAR T cell therapy for ALL
$664,070Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers
$664,029Kathrin Milbury · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Mechanisms of immunomodulatory and anti-tumor actions of Polysaccharide Krestin
$664,000Mary L. Disis · University Of Washington · R01 · FY2009 · AT
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$663,998Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA